Is Topiramate Effective in Treating Dizziness in Patient's With Migraine-Associated Dizziness

• Status: Withdrawn
• Trial end date: 1969-12-31
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to determine whether topiramate effective in treating dizziness symptoms that are associated with migraine headaches.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: University of California, San Francisco
• Collaborator: American Academy of Otolaryngology-Head and Neck Surgery Foundation
• Treatments: Lactulose; Topiramate

Criteria

Inclusion Criteria:

• Clinical diagnosis of migraine-associated dizziness.

Exclusion Criteria:

• Previous or current use of topiramate prior to study enrollment.

• Need for continued use of the following medications for any medical reason during the study: ergots, anti-epileptics, beta-blockers, calcium channel blockers, monoamine oxidase inhibitors, high-dose magnesium, high-dose riboflavin, corticosteroids, local anesthetics, botulinum toxin, or herbal preparations.

• History of nephrolithiasis.

• Women whom are pregnant or breastfeeding.

• Patients with known sensitivity to topiramate.

• Patients with a history of glaucoma.

• Patients with severe medical condition(s) that in the view of the investigator prohibits participation in the study.